Rituximab is preferable to cyclophosphamide for treatment of membranous nephropathy: COMMENTARY

2021 
This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the PRO: 10.34067/KID.0001842021 and the CON: 10.34067/KID.0001432021
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []